MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$9,225,387
EPS
-$0.14
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development expenses
6,620,323
5,232,541
8,449,085.5*
4,968,596
Acquisition-related costs (note 5)
-
-
919,904.5*
-
General and administrative expenses
2,142,961
2,297,358
-2,481,389.5*
1,761,007
Operating loss
8,763,284
7,529,899
6,887,600.5*
6,729,603
Employee retention tax credit
-
-
28,393.5*
-
Grant income
-
-
22,077*
138,299
Interest expense
467,634
27,974
575,687*
16,532
Interest income
7,620
21,275
82,944*
6,060
Other expense
-
-
-
185,019
Change in fair value of kineta merger holdback shares
-
-
2,263,585.75*
-315,660
Loss on kineta employee separation payments assumed from merger
-
-
46,254.75*
-
Total other (expense) income
-460,014
-6,699
1,775,058.5*
-372,852
Net loss
-9,223,298
-7,536,598
-5,112,542*
-7,102,455
Series a preferred cash dividend
2,089
2,089
2,089*
2,089
Deemed dividend on warrant modifications
-
-
0*
-
Net loss attributable to common stockholders
-9,225,387
-7,538,687
-5,114,631
-7,104,544
Basic EPS
-0.14
-0.13
-0.105
-0.14
Diluted EPS
-0.14
-0.13
-0.105
-0.14
Basic Average Shares
63,963,513
60,010,237
48,560,063
50,666,430
Diluted Average Shares
63,963,513
60,010,237
48,560,063
50,666,430
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$9,225,387 (3.15%↑ Y/Y)Net loss-$9,223,298 (3.16%↑ Y/Y)Series a preferred cashdividend$2,089 (0.00%↑ Y/Y)Operating loss$8,763,284 (-11.27%↓ Y/Y)Total other (expense)income-$460,014 (-230.64%↓ Y/Y)Interest income$7,620 (-74.14%↓ Y/Y)Research and developmentexpenses$6,620,323 (34.37%↑ Y/Y)General andadministrative expenses$2,142,961 (-56.70%↓ Y/Y)Interest expense$467,634

TuHURA Biosciences, Inc. NV (HURA)

TuHURA Biosciences, Inc. NV (HURA)